对血液透析患者可能不适当的药物进行针对性处方的实施。

Savannah Gerardi, David Sperlea, Shirel Ora-Lee Levy, Kaitlin Bondurant-David, Sébastien Dang, Pierre-Marie David, Annie Lizotte, Lysane Senécal, François Paquette, Marie-Claude Vanier
{"title":"对血液透析患者可能不适当的药物进行针对性处方的实施。","authors":"Savannah Gerardi,&nbsp;David Sperlea,&nbsp;Shirel Ora-Lee Levy,&nbsp;Kaitlin Bondurant-David,&nbsp;Sébastien Dang,&nbsp;Pierre-Marie David,&nbsp;Annie Lizotte,&nbsp;Lysane Senécal,&nbsp;François Paquette,&nbsp;Marie-Claude Vanier","doi":"10.1093/ajhp/zxac190","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Patients on hemodialysis have a high risk of medication-related problems. Studies using deprescribing algorithms to reduce the number of inappropriate medications in this population have been published, but none have used a patient-partnership approach. Our study evaluated the impact of a similar intervention with a patient-partnership approach.</p><p><strong>Methods: </strong>The objective was to describe the implementation of a pharmacist-led intervention with a patient-partnership approach using deprescribing algorithms and its impact on the reduction of inappropriate medications in patients on hemodialysis. Eight algorithms were developed by pharmacists and nephrologists to assess the appropriateness of medications. Pharmacists identified patients taking targeted medications. Following patient enrollment, pharmacists assessed medications with patients and applied the algorithms. With patient consent, deprescription was suggested to nephrologists if applicable. Specific data on each targeted medication were collected at 4 and 16 weeks. Descriptive statistics were used to examine the effects of the deprescribing intervention.</p><p><strong>Results: </strong>Of 270 patients, 256 were taking at least one targeted medication. Of the 122 patients taking at least one targeted medication who were approached to participate, 66 were included in the study. At enrollment, these patients were taking 252 targeted medications, of which 59 (23.4%) were determined to be inappropriate. Deprescription was initiated for 35 of these 59 medications (59.3%). At 4 weeks, 33 of the 59 medications (55.9%) were still deprescribed, while, at 16 weeks, 27 of the 59 medications (45.8%) were still deprescribed. Proton pump inhibitors and benzodiazepines or Z-drugs were the most common inappropriate medications, and allopurinol was the most deprescribed medication.</p><p><strong>Conclusion: </strong>A pharmacist-led intervention with a patient-partnership approach and using deprescribing algorithms reduced the number of inappropriate medications in patients on hemodialysis.</p>","PeriodicalId":520552,"journal":{"name":"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","volume":" ","pages":"S128-S135"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.\",\"authors\":\"Savannah Gerardi,&nbsp;David Sperlea,&nbsp;Shirel Ora-Lee Levy,&nbsp;Kaitlin Bondurant-David,&nbsp;Sébastien Dang,&nbsp;Pierre-Marie David,&nbsp;Annie Lizotte,&nbsp;Lysane Senécal,&nbsp;François Paquette,&nbsp;Marie-Claude Vanier\",\"doi\":\"10.1093/ajhp/zxac190\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>Patients on hemodialysis have a high risk of medication-related problems. Studies using deprescribing algorithms to reduce the number of inappropriate medications in this population have been published, but none have used a patient-partnership approach. Our study evaluated the impact of a similar intervention with a patient-partnership approach.</p><p><strong>Methods: </strong>The objective was to describe the implementation of a pharmacist-led intervention with a patient-partnership approach using deprescribing algorithms and its impact on the reduction of inappropriate medications in patients on hemodialysis. Eight algorithms were developed by pharmacists and nephrologists to assess the appropriateness of medications. Pharmacists identified patients taking targeted medications. Following patient enrollment, pharmacists assessed medications with patients and applied the algorithms. With patient consent, deprescription was suggested to nephrologists if applicable. Specific data on each targeted medication were collected at 4 and 16 weeks. Descriptive statistics were used to examine the effects of the deprescribing intervention.</p><p><strong>Results: </strong>Of 270 patients, 256 were taking at least one targeted medication. Of the 122 patients taking at least one targeted medication who were approached to participate, 66 were included in the study. At enrollment, these patients were taking 252 targeted medications, of which 59 (23.4%) were determined to be inappropriate. Deprescription was initiated for 35 of these 59 medications (59.3%). At 4 weeks, 33 of the 59 medications (55.9%) were still deprescribed, while, at 16 weeks, 27 of the 59 medications (45.8%) were still deprescribed. Proton pump inhibitors and benzodiazepines or Z-drugs were the most common inappropriate medications, and allopurinol was the most deprescribed medication.</p><p><strong>Conclusion: </strong>A pharmacist-led intervention with a patient-partnership approach and using deprescribing algorithms reduced the number of inappropriate medications in patients on hemodialysis.</p>\",\"PeriodicalId\":520552,\"journal\":{\"name\":\"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists\",\"volume\":\" \",\"pages\":\"S128-S135\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-11-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/ajhp/zxac190\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/ajhp/zxac190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

目的:血液透析患者发生药物相关问题的风险较高。已经发表了使用处方解方算法来减少这一人群中不适当药物数量的研究,但没有人使用患者-伙伴关系方法。我们的研究评估了采用患者-伙伴关系方法的类似干预的影响。方法:目的是描述使用处方解方算法的药剂师主导的患者伙伴关系干预方法的实施及其对减少血液透析患者不适当药物的影响。药剂师和肾病学家开发了8种算法来评估药物的适当性。药剂师确定了服用靶向药物的患者。在患者登记后,药剂师与患者一起评估药物并应用算法。在患者同意的情况下,如果适用,建议肾科医生去处方。在第4周和第16周收集每种靶向药物的具体数据。描述性统计用于检验描述性干预的效果。结果:270例患者中,256例患者至少服用了一种靶向药物。在接受至少一种靶向药物治疗的122名患者中,有66人被纳入了研究。在入组时,这些患者服用了252种靶向药物,其中59种(23.4%)被确定为不合适。这59种药物中有35种(59.3%)开始去处方。第4周时,59种药物中有33种(55.9%)仍未开药;第16周时,59种药物中有27种(45.8%)仍未开药。质子泵抑制剂和苯二氮卓类药物或z类药物是最常见的不适当药物,别嘌呤醇是最不适当的药物。结论:药剂师主导的干预与患者合作的方法和使用处方解方算法减少了不适当的药物在血液透析患者的数量。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Implementation of targeted deprescribing of potentially inappropriate medications in patients on hemodialysis.

Purpose: Patients on hemodialysis have a high risk of medication-related problems. Studies using deprescribing algorithms to reduce the number of inappropriate medications in this population have been published, but none have used a patient-partnership approach. Our study evaluated the impact of a similar intervention with a patient-partnership approach.

Methods: The objective was to describe the implementation of a pharmacist-led intervention with a patient-partnership approach using deprescribing algorithms and its impact on the reduction of inappropriate medications in patients on hemodialysis. Eight algorithms were developed by pharmacists and nephrologists to assess the appropriateness of medications. Pharmacists identified patients taking targeted medications. Following patient enrollment, pharmacists assessed medications with patients and applied the algorithms. With patient consent, deprescription was suggested to nephrologists if applicable. Specific data on each targeted medication were collected at 4 and 16 weeks. Descriptive statistics were used to examine the effects of the deprescribing intervention.

Results: Of 270 patients, 256 were taking at least one targeted medication. Of the 122 patients taking at least one targeted medication who were approached to participate, 66 were included in the study. At enrollment, these patients were taking 252 targeted medications, of which 59 (23.4%) were determined to be inappropriate. Deprescription was initiated for 35 of these 59 medications (59.3%). At 4 weeks, 33 of the 59 medications (55.9%) were still deprescribed, while, at 16 weeks, 27 of the 59 medications (45.8%) were still deprescribed. Proton pump inhibitors and benzodiazepines or Z-drugs were the most common inappropriate medications, and allopurinol was the most deprescribed medication.

Conclusion: A pharmacist-led intervention with a patient-partnership approach and using deprescribing algorithms reduced the number of inappropriate medications in patients on hemodialysis.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信